Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
AOD 9604 is a modified fragment of human growth hormone (HGH) designed to target fat metabolism without affecting blood sugar or growth hormone levels significantly
Repeated injection in the same exact spot causes lipohypertrophy, a thickening of the subcutaneous fat tissue that creates permanent or semi-permanent bumps
Three distinct mechanisms: AMPK activation (MOTS-c), beta-3 adrenergic lipolysis (AOD-9604), and GHRH-stimulated growth hormone release (Tesamorelin)
Injectable NAD+ delivers the coenzyme directly into the bloodstream, bypassing the digestive system for more efficient absorption compared to oral forms or supplements
Its also why we caution patients strongly against treatment with Dermapen at spas and salons
If you are comparing service options, start with our NAD+ IV treatment page or talk with the team through contact
